April 7th, 2008

The New York Times, Pre-Emption and ORTHO EVRA

Yesterday, The New York Times published an article entitled, “Drug Makers Near Old Goal: A Legal Shield.” The article is primarily about a legal doctrine called pre-emption, but ORTHO EVRA®, the birth control patch marketed in the U.S. by our Ortho-McNeil unit is prominently featured. For those interested, my colleagues at Ortho McNeil have published their position on this article on their website.

Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.